(S (NP (PRP We)) (ADVP (RB first)) (VP (VBD addressed) (SBAR (IN whether) (S (NP (NP (JJ somatic) (NNS mutations)) (VP (ADVP (RB typically)) (VBN involved) (PP (IN in) (NP (NN cancer))))) (VP (MD may) (VP (VB increase) (, ,) (PP (IN in) (NP (DT a) (ADJP (RB statistically) (JJ meaningful)) (NN manner))) (, ,) (NP (NP (DT the) (NN similarity)) (PP (IN between) (NP (NP (JJ common) (NNS pathogens)) (CC and) (NP (DT the) (JJ human) (NN exome)))))))))) (. .))
